Neuland Laboratories share price hit a new high of Rs 14,500 on the BSE, surging 16% intraday and closing 12.8% higher at Rs 14,100 on expectation of strong Q2FY25 earnings. The company’s stock has more than doubled in the last four months, recording its highest-ever quarterly revenue in Q1FY25 at Rs 444.4 crore, driven by growth in the CMS business, with healthy Ebitda margins. Neuland Labs, a pharmaceutical manufacturer, is focusing on expanding its CMS business and expects business momentum to pick up from FY26 onwards, supported by a growing market for API within the CDMO sector.
Full Article
Is CoreWeave Stock a Buy Now?
Investing in the current stock market is challenging due to the volatile macroeconomic environment influenced by fluctuating tariff policies from the Trump administration. However, the artificial intelligence sector presents a promising investment opportunity as companies strive to enhance their AI capabilities, with stocks like CoreWeave (NASDAQ: CRWV) demonstrating significant potential; after going public at $40 per share in March, its stock peaked at $166.63 in June, remaining over three times its IPO price. Investors are...
Read more